1. Home
  2. DBVT vs ALCO Comparison

DBVT vs ALCO Comparison

Compare DBVT & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • ALCO
  • Stock Information
  • Founded
  • DBVT 2002
  • ALCO 1960
  • Country
  • DBVT France
  • ALCO United States
  • Employees
  • DBVT N/A
  • ALCO N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • ALCO
  • Sector
  • DBVT Health Care
  • ALCO
  • Exchange
  • DBVT Nasdaq
  • ALCO Nasdaq
  • Market Cap
  • DBVT 260.5M
  • ALCO 257.5M
  • IPO Year
  • DBVT N/A
  • ALCO N/A
  • Fundamental
  • Price
  • DBVT $15.48
  • ALCO $33.53
  • Analyst Decision
  • DBVT Buy
  • ALCO
  • Analyst Count
  • DBVT 4
  • ALCO 0
  • Target Price
  • DBVT $14.81
  • ALCO N/A
  • AVG Volume (30 Days)
  • DBVT 94.7K
  • ALCO 21.3K
  • Earning Date
  • DBVT 11-05-2025
  • ALCO 08-12-2025
  • Dividend Yield
  • DBVT N/A
  • ALCO 0.60%
  • EPS Growth
  • DBVT N/A
  • ALCO N/A
  • EPS
  • DBVT N/A
  • ALCO N/A
  • Revenue
  • DBVT $3,800,000.00
  • ALCO $44,199,000.00
  • Revenue This Year
  • DBVT $1,743.46
  • ALCO N/A
  • Revenue Next Year
  • DBVT $1,044.34
  • ALCO N/A
  • P/E Ratio
  • DBVT N/A
  • ALCO N/A
  • Revenue Growth
  • DBVT N/A
  • ALCO N/A
  • 52 Week Low
  • DBVT $2.21
  • ALCO $24.23
  • 52 Week High
  • DBVT $15.95
  • ALCO $35.01
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 87.03
  • ALCO N/A
  • Support Level
  • DBVT $9.19
  • ALCO N/A
  • Resistance Level
  • DBVT $14.44
  • ALCO N/A
  • Average True Range (ATR)
  • DBVT 0.84
  • ALCO 0.00
  • MACD
  • DBVT 0.64
  • ALCO 0.00
  • Stochastic Oscillator
  • DBVT 100.00
  • ALCO 0.00

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

Share on Social Networks: